title: Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndrome.
authors: Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
authors: Preetesh
authors: P
authors: Jain
authors: Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
authors: Srdan
authors: S
authors: Verstovsek
authors: Departments of, Hematopathology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
authors: Sanam
authors: S
authors: Loghavi
authors: Departments of, Hematopathology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
authors: Jeffrey L
authors: JL
authors: Jorgensen
authors: Departments of, Hematopathology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
authors: Keyur P
authors: KP
authors: Patel
authors: Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
authors: Zeev
authors: Z
authors: Estrov
authors: Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
authors: Luis
authors: L
authors: Fayad
authors: Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
authors: Naveen
authors: N
authors: Pemmaraju
mesh_terms: D000328:Adult; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology*; D005871:Castleman Disease / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006651:Histocytochemistry; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008198:Lymph Nodes / Q000187:drug effects / Q000473:pathology; D008297:Male; D008533:Megakaryocytes / Q000187:drug effects / Q000473:pathology*; D010950:Plasma Cells / Q000187:drug effects / Q000473:pathology; D055728:Primary Myelofibrosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D012074:Remission Induction; D000069283:Rituximab / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007155:Immunologic Factors; D000069283:Rituximab